The entry criteria were age < 73 years, severe chest pain for >30 minutes (but no longer than four hours), ST segment elevation of 01 mV in at least two contiguous electrocardiographic leads, no left bundle branch block on the qualifying entry electrocardiogram, no congestive heart failure before admission, no history of cardiac surgery, diastolic blood pressure < 120 mm Hg, no history of terminal illness, no bleeding predisposition (that is, oral anticoagulant treatment, recent trauma, past bleeding history, or cerebrovascular accident during the past six months).
THROMBOLYTIC REGIMEN
A total dose of 120 mg alteplase (GI 1035, supplied by Boehringer Ingelheim, West Germany) was given during a 6 hour infusion that consistgd of a 10 mg bolus followed by a continuous infusion of 50 mg during the first hour, 20 mg in the second hour, and 10 mg during each of the following four hours.
Concomitantly, a bolus of 5000 IU of heparin was infused followed by 25 000 IU per 24 hours. The dose was adjusted to keep the activated partial thromboplastin time 1-5 to 2 times the baseline. Heparin infusion was continued for at least five days except when patients underwent a successful coronary angioplasty (then heparin treatment was stopped after 24 hours); bled, or were referred for urgent (before discharge) coronary bypass surgery (then heparin was continued until operation). Aspirin (250 mg) was given daily after the first 24 hours and continued during the follow up. Conventional antianginal and anticongestive treatment was used as needed. All patients were treated prophylactically with 2 g of intravenous lignocaine for the first 24 hours. For purpose of analysis, the left ventricular ejection fraction at discharge was considered to be zero for the four patients who died before discharge.
PATIENT EVALUATION All patients stayed in the coronary care unit for at least 24 hours. Patients scored their level of pain from 1 to 10 with the pain level before treatment defined as 10. Significant relief of pain was defined as a reduction of at least 50% within one hour after the start of alteplase infusion. Serial 12 lead electrocardiogram tracings were obtained every three hours during the first 24 hours and at least once daily thereafter until discharge. In addition, a 12 lead electrocardiogram was obtained every 15-30 minutes during the first two hours of treatment or until the ST segment elevation was resolved. Blood samples for creatine kinase were collected every three hours during the first 24 hours. The creatine kinase MB isoenzyme fraction was calculated from the sample in which the creatine kinase concentration was highest. After discharge, patients had follow up clinic visits at 2, 6, and 12 months and once annually thereafter. Surviving patients completed a one year follow up.
CLINICAL DEFINITIONS
Infarction.-The diagnosis of myocardial infarction was based on the occurrence of ischaemic chest pain lasting > 30 minutes and accompanied by ST segment elevation of at least 0-1 mV in two contiguous electrocardiographic leads, followed by either an increase in the serum concentration of the creatine kinase MB fraction of > 5%, or the appearance of new Q waves not present on the initial electrocardiogram. Abnormal Q waves were those lasting 0 03, at least 4 mm deep, and > 250% of the height of the ensuing R wave all in leads other than aVR or V1.
Rapid resolution of ST segment elevation.-As in earlier reports,'3 we calculated the sum of ST segment elevations (Z ST) on the electrocardiograms recorded at admission and 1 hour after treatment. Electrocardiograms were evaluated within the first 24 hours after admission by two independent observers, one from the coronary care unit treating the patient and one observer who was not involved in the care of these patients. In cases of disagreement, a third opinion was sought. Resolution of ST segment elevation was defined as a decrease of at least 50% of the baseline £ ST elevation.
Patency.-A TIMI grade of 2 or 3 signified patency of the infarct related coronary artery. Occlusion of the infarct-related artery was defined as TIMI grade 0 or 1."
Clinical prognostic groups.-Patients were categorised as having a first infarction in the anterior or inferior wall or a history of infarction irrespective of the location of the current infarction. (33-90o) ST segment elevation persisted despite an hour of alteplase infusion. The two groups were generally comparable. In the group of patients with rapid resolution of ST elevation, however, anterior wall infarction was less common, previous infarction was more common, and the time from onset of symptoms to the start of treatment was longer (124 (51) v 112 (44) min respectively, p = 0-053). In the patients with anterior wall infarction with rapid resolution of ST elevation and in those without, baseline Z ST elevation was 18-3 (9-4) and 22 3 (12-8) respectively (p = NS). In those with inferior wall infarction, baseline Z ST elevation was 8-4 (4 2) in those with rapid resolution of ST elevation and 10-5 (6-8) in those without (p = NS). The baseline £ ST elevation in patients with previous infarction was similar in patients with rapid resolution of ST elevation and those without (11-8 (5 5) v 15-3 (9 9), p = NS).
In 10 patients the initial clinical picture of myocardial infarction was not confirmed by an increase in the activity of the MB isoenzyme fraction of creatine kinase or the development of new Q waves on their electrocardiograms. All 10 patients showed rapid resolution of ST elevation. We present the results for the total group, because exclusion of these patients from analysis did not affect the differences between the patients with rapid ST resolution and the patients with persistent ST elevation. 8/44 (16 6) with rapid resolution of pain and ST segment elevation died: one in the third month of a ruptured septic aortic aneurysm and the other after eight months ofhepatic malignancy. Thus overall mortality among the 97 patients with persistent ST elevation was higher than that in the 189 patients with rapid resolution of ST elevation (13 4% v 2 6%, p < 0 0007) (fig 3) .
CLINICAL MARKERS AND ANGIOGRAPHIC PATENCY Table 5 shows the correlation between the clinical response to thrombolytic treatment and patency of the infarct artery during coronary angiography after three days. At that time the patency rate of the infarct artery was higher in patients with rapid resolution of ST elevation (8666%ov76&1%, p = 004).
In contrast with the strong association between a favourable clinical outcome and rapid resolution of ST segment elevation, the patency of the infarct artery at 72 hours was not associated with less creatine kinase release, preservation of left ventricular function, or lower morbidity after alteplase thrombolysis (table 6) . Total mortality among angiographically assessed patients was lower in those with a patent infarct artery (eight of 231 v 5 of 46, p = 0-01). Even when the five deaths in patients who did not survive to angiography were included, persistent ST elevation was more common than occlusion of the infarct artery among patients who died (13 patients with persistent ST elevation compared with five patients with an occluded infarct artery among 18 who died).
MULTIVARIATE ANALYSIS OF FACTORS AFFECTING THE CLINICAL OUTCOME VARIABLES
Preliminary logistic regression analysis indicated that there were four measures related to the change in the ST elevation after treatment-that is, the continuous variables Z ST at admission; Z ST one hour after treatment initiation; ratio of this value to the admission Z ST; or the categorical definition of < 50%0 reduction of Z ST from admission level (persistent ST elevation)-but only the last variable was strongly associated with all outcome variables and excluded the other three variables from the model. Consequently, the final analysis was done with persistent Z ST elevation alone.
The analysis evaluated the effect of each risk variable on each of the outcome variables after its association with other risk variables is taken group.bmj.com on June 24, 2017 -Published by http://heart.bmj.com/ Downloaded from Our data indicate that the rapid resolution of ST segment elevation was significantly associated with a more favourable clinical outcome. In part, this more favourable outcome may have been related to the better baseline clinical characteristics in this group. However, even after the effect of this initial advantage was accounted for by multivariate analysis, this early clinical sign of reperfusion was significantly associated with a smaller infarct, as evidenced by a smaller release of creatine kinase, better preservation of left ventricular function, and significantly lower morbidity and mortality. Moreover, resolution of ST segment elevation was a better predictor of clinical outcome, including mortality, than was the patency rate determined by coronary angiography three days after admission (table 6) . Multivariate analysis showed that the better outcome in the patients with rapid ST resolution was independent of their better baseline status (that is the lower rate of old or anterior wall infarctions or both as well as the initially lower 2 ST). Our analysis indicates that the categorical variable of 5000 resolution from the initial £ ST elevation to the one hour £ ST value was also superior to the change in Z ST as a continuous variable.
These findings are consistent with those of the open-label phase of the TIMI Trial in which a decline in ST elevation from entry to two hours correlated with better left ventricular function in patients with acute myocardial infarction treated by thrombolysis. 9 ST segment elevation resolved more rapidly in patients treated with streptokinase than in the control group.'320 Also, ST segment elevation decreased significantly within one and three hours after treatment in patients with confirmed angiographic reperfusion.'42 '22 Despite this evidence, it was recently argued that clinical markers of reperfusion were inadequate predictors of early recanalisation of the infarct artery after thrombolytic treatment. " In our patients, rapid resolution of ST elevation was associated with a higher patency rate in the infarct-related artery three days after treatment began. The difference in the patency rate between the two patient groups, though significant, was small (86-7 v 76.90%). In view of this small difference in patency between the two groups, how could resolution of ST elevations predict the clinical outcome of our patients who were treated with thrombolysis? Moreover, how can the high patency rate in the group with persistent ST elevation be reconciled with their unfavourable outcome?
It could have been argued that angiography 72 hours after thrombolysis does not reflect the patency rate when alteplase infusion ended and that in patients with persistent ST elevation an earlier angiography would have detected lower patency rates. However, the patency rate (760o) we saw (at 72 hours) in patients with persistent ST elevation was significantly higher than the 4000 rate reported in patients with a three day old myocardial infarction who were not treated by thrombolysis.2" Thus coronary thrombolysis was successful in a substantial proportion of our patients with persistent ST elevation. But perhaps reperfusion was more effective in patients with rapid ST resolution than in those with persistent ST elevation. The effectiveness of the reperfusion may have been influenced by additional factors such as the existence of subtotal coronary occlusion or good collateral circulation, the rate and promptness of coronary artery recanalisation, and the residual stenosis in the infarct artery.
Thus rapid resolution of ST segment elevation may indicate a more effective reperfusion leading to a better clinical outcome. This possibility is supported by the fact that in the multivariate analysis rapid resolution of ST segment elevation was associated with a significantly favourable outcome with respect to all outcome variables after the effect of all baseline variables was accounted for. When ST segment elevation persisted despite one hour of alteplase thrombolysis, reperfusion was probably less effective even when angiographic patency was eventually seen. Because mechanical revascularisation procedures were performed to a similar extent in both groups, this factor could not have accounted for the better outcome of patients with rapid resolution of ST elevation.
Abrupt resolution of pain, though it was much more common among patients with rapid ST resolution, did not have any additional predictive power when combined with rapid resolution of ST elevation. However, as a sign of reperfusion, pain resolution is not very specific, partly because of the use of analgesics. Nevertheless, the outcome in patients with rapid resolution of ST elevation but persistent ischaemic pain was similar to that in patients with resolution of both pain and ST elevation.
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